Parathyroid cancer epidemiology and demographics

Parathyroid cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Parathyroid cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Parathyroid cancer epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Parathyroid cancer epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Parathyroid cancer epidemiology and demographics
CDC on Parathyroid cancer epidemiology and demographics
Parathyroid cancer epidemiology and demographics in the news
Blogs on Parathyroid cancer epidemiology and demographics
Directions to Hospitals Treating Type chapter name here
Risk calculators and risk factors for Parathyroid cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. Parathyroid cancer affects men and women equally.

Epidemiology and Demographics

Prevalence

• In developed countries, the prevalence of parathyroid cancer in United States estimated to be .005%

Incidence

• In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 individuals.

Age

• The median age in most series is between 45 and 51 years.

Gender

• The ratio of affected female to maile is 1:1.

Developed Countries

• In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary hyperparathyroidism.

References

Template:WikiDoc Sources